BIO vs. MTD, WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, and A
Should you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry.
Bio-Rad Laboratories vs.
Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, community ranking, risk, valuation and institutional ownership.
In the previous week, Mettler-Toledo International had 11 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 26 mentions for Mettler-Toledo International and 15 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 0.85 beat Bio-Rad Laboratories' score of 0.79 indicating that Mettler-Toledo International is being referred to more favorably in the news media.
65.2% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 17.1% of Bio-Rad Laboratories shares are held by company insiders. Comparatively, 1.9% of Mettler-Toledo International shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Bio-Rad Laboratories currently has a consensus target price of $395.20, indicating a potential upside of 51.46%. Mettler-Toledo International has a consensus target price of $1,380.50, indicating a potential upside of 6.79%. Given Bio-Rad Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.
Mettler-Toledo International has a net margin of 22.29% compared to Bio-Rad Laboratories' net margin of -71.86%. Bio-Rad Laboratories' return on equity of 3.90% beat Mettler-Toledo International's return on equity.
Bio-Rad Laboratories has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500.
Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.
Bio-Rad Laboratories received 1 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 64.70% of users gave Bio-Rad Laboratories an outperform vote while only 56.55% of users gave Mettler-Toledo International an outperform vote.
Summary
Mettler-Toledo International beats Bio-Rad Laboratories on 11 of the 18 factors compared between the two stocks.
Get Bio-Rad Laboratories News Delivered to You Automatically
Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bio-Rad Laboratories Competitors List
Related Companies and Tools
This page (NYSE:BIO) was last updated on 3/10/2025 by MarketBeat.com Staff
Free BIO Stock Alerts